Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis D Falo

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cellsAdrian E Morelli, J Peter Rubin, Geza Erdos, et al.
Oncoimmunology|May 6, 2015
Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potencyYi Zhang, Shenghe Tian, Zuqiang Liu, et al.
Science Translational Medicine|December 11, 2024
Agonism of the glutamate receptor GluK2 suppresses dermal mast cell activation and cutaneous inflammationYouran R Zhang, Swapnil Keshari, Kazuo Kurihara, et al.
Iscience|September 5, 2022
A microarray patch SARS-CoV-2 vaccine induces sustained antibody responses and polyfunctional cellular immunityStephen C Balmert, Zohreh Gholizadeh Ghozloujeh, Cara Donahue Carey, et al.
The Journal of Investigative Dermatology|October 31, 2016
A Topical Mitochondria-Targeted Redox-Cycling Nitroxide Mitigates Oxidative Stress-Induced Skin DamageRhonda M Brand, Michael W Epperly, J Mark Stottlemyer, et al.
Blood|October 24, 2002
Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine productionAdrian E Morelli, Adriana T Larregina, William J Shufesky, et al.
Cancer Research|March 28, 2019
Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor GrowthGalina V Shurin, Oleg Kruglov, Fei Ding, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumorsKotaro Sasaki, Angela D Pardee, Yanyan Qu, et al.
Blood|February 1, 2013
Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12Brian M Janelsins, Tina L Sumpter, Olga A Tkacheva, et al.
Ebiomedicine|April 7, 2020
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational developmentEun Kim, Geza Erdos, Shaohua Huang, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cellsAdrian E Morelli, J Peter Rubin, Geza Erdos, et al.
Oncoimmunology|May 6, 2015
Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potencyYi Zhang, Shenghe Tian, Zuqiang Liu, et al.
Science Translational Medicine|December 11, 2024
Agonism of the glutamate receptor GluK2 suppresses dermal mast cell activation and cutaneous inflammationYouran R Zhang, Swapnil Keshari, Kazuo Kurihara, et al.
Iscience|September 5, 2022
A microarray patch SARS-CoV-2 vaccine induces sustained antibody responses and polyfunctional cellular immunityStephen C Balmert, Zohreh Gholizadeh Ghozloujeh, Cara Donahue Carey, et al.
The Journal of Investigative Dermatology|October 31, 2016
A Topical Mitochondria-Targeted Redox-Cycling Nitroxide Mitigates Oxidative Stress-Induced Skin DamageRhonda M Brand, Michael W Epperly, J Mark Stottlemyer, et al.
Blood|October 24, 2002
Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine productionAdrian E Morelli, Adriana T Larregina, William J Shufesky, et al.
Cancer Research|March 28, 2019
Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor GrowthGalina V Shurin, Oleg Kruglov, Fei Ding, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumorsKotaro Sasaki, Angela D Pardee, Yanyan Qu, et al.
Blood|February 1, 2013
Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12Brian M Janelsins, Tina L Sumpter, Olga A Tkacheva, et al.
Ebiomedicine|April 7, 2020
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational developmentEun Kim, Geza Erdos, Shaohua Huang, et al.
Pageof 8